Get started
NUREXONE BIOLOGIC INC.NUREXONE BIOLOGIC INC.NUREXONE BIOLOGIC INC.

NUREXONE BIOLOGIC INC.

No trades
See on Supercharts
Overview
Financials News Ideas Forecast

J90 chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪19.54 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.078EUR
Net income (FY)
‪−3.36 M‬EUR
Revenue (FY)
—
Shares float
‪43.77 M‬
Beta (1Y)
−0.78

About NUREXONE BIOLOGIC INC

Sector
Health Technology
CEO
Lior Shaltiel
Headquarters
Bnei-Brak
Website
nurexone.com
Founded
2011
FIGI
BBG00H90W3P3
NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. It focuses on the treatment of spinal cord injury, traumatic brain injury, and other brain and neurological indications. The company was founded on June 27, 2011 and is headquartered in Bnei-Brak, Israel.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange NUREXONE BIOLOGIC INC. stocks are traded under the ticker J90.
NUREXONE BIOLOGIC INC. is going to release the next earnings report on May 22, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track NUREXONE BIOLOGIC INC. financials in yearly and quarterly reports right on TradingView.
J90 net income for the last quarter is ‪−686.18 K‬ EUR, while the quarter before that showed ‪−1.08 M‬ EUR of net income which accounts for 36.56% change. Track more NUREXONE BIOLOGIC INC. financial stats to get the full picture.
No, J90 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, J90 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NUREXONE BIOLOGIC INC. stock right from TradingView charts — choose your broker and connect to your account.
J90 reached its all-time high on Feb 19, 2024 with the price of 0.920 EUR, and its all-time low was 0.104 EUR and was reached on Sep 21, 2023. View more price dynamics on J90 chart.
See other stocks reaching their highest and lowest prices.
We've gathered analysts' opinions on NUREXONE BIOLOGIC INC. future price: according to them, J90 price has a max estimate of 2.73 EUR and a min estimate of 2.73 EUR. Watch J90 chart and read a more detailed NUREXONE BIOLOGIC INC. stock forecast: see what analysts think of NUREXONE BIOLOGIC INC. and suggest that you do with its stocks.